3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
11
Terminated
2
Withdrawn
1
Unknown
1
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
2
Wounds and Injuries
1
Ulcer
1
Skin Ulcer
1
Opioid-Related Disorders
1
Lymphoma, Follicular
1
Chronic Pain
1
Cancer Pain
1
Adenocarcinoma
1
Interventions
resiniferatoxin
1
Transcranial Direct Current Stimulation
1
Standard of Care
1
Patient Education as Topic
1
Passive Cutaneous Anaphylaxis
1
Morphine
1
Methadone
1
Infusions, Intravenous
1
Administration, Sublingual
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Cancer Pain
×
Morphine
×
Clear all
NCT05325164
2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3
Withdrawn